Release Date: 28/07/14 12:51 Summary: Chairman's Address to Shareholder Meeting Price Sensitive: No Download Document 77.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%